Diabetes Care Devices Market, By Diabetes (Type 1, Type 2, and Gestational), By Device, By Distribution Channel, By Technology, By End-Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV4967
|
Published Date
March 2026
|
Pages
336
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Diabetes Care Devices Market size was valued at US$ 65,460.82 Million in 2025, expanding at a CAGR of 6.57% from 2026 to 2033.
Diabetes care devices are medical tools designed to help individuals monitor and manage their blood sugar levels effectively in daily life. These devices include blood glucose meters for routine testing, continuous glucose monitoring (CGM) systems that track glucose levels throughout the day, and insulin delivery devices such as pens and pumps. They empower patients to better understand their condition and take timely actions, including adjusting diet, medication, or insulin doses. Designed with user-friendliness in mind, these tools facilitate accurate diabetes management for both patients and healthcare providers.
The global diabetes care devices market is experiencing steady growth, driven by the rising prevalence of diabetes and increasing awareness of the importance of regular monitoring. According to the World Health Organization (WHO), over 422 million people worldwide are living with diabetes, with numbers continuing to rise, particularly in developing countries. This expanding patient population fuels demand for reliable monitoring and treatment solutions. Additionally, government initiatives support diabetes management and early diagnosis. For example, India’s Ministry of Health and Family Welfare promotes programs such as NP-NCD, which encourage early detection and regular monitoring, further boosting the adoption of glucose monitoring devices in both hospitals and home settings.
Diabetes Care Devices Market- Market Dynamics
Rising Emphasis on Early Diagnosis and Preventive Healthcare
The growing emphasis on early detection and preventive healthcare is a key driver of market expansion. As awareness of proactive health management increases, more individuals are opting for routine screening and regular monitoring, even before severe symptoms emerge. This trend promotes the use of glucose monitoring devices at an early stage, enabling better disease management and reducing the risk of long-term complications. Healthcare providers and public health organizations are also advocating for timely testing and lifestyle management, further boosting the demand for user-friendly monitoring tools. From an industry perspective, companies are responding to this trend with strong adoption rates. Dexcom has reported continued growth in users of its continuous glucose monitoring (CGM) systems, reflecting rising adoption for proactive care. Similarly, Roche has highlighted robust demand for its Accu-Chek glucose monitoring solutions, widely used for daily testing and preventive health management. Overall, the increasing focus on routine health check-ups and early intervention is driving sustained growth in the diabetes care devices market.
Diabetes Care Devices Market- Segmentation Analysis:
The Global Diabetes Care Devices Market is segmented on the basis of Diabetes, Device, Distribution Channel, Technology, End-Use, and Region.
Within the diabetes market segmentation, the Type 2 diabetes segment is expected to maintain prominence, as it accounts for the majority of diagnosed cases worldwide and is closely associated with lifestyle factors, aging populations, and changing dietary habits. Growing awareness has led more individuals with Type 2 diabetes to adopt regular glucose monitoring devices for effective disease management. Governments and healthcare systems are also encouraging early screening and continuous monitoring to prevent complications. From an industry perspective, Abbott Laboratories has reported strong global adoption of its Freestyle Libre continuous glucose monitoring (CGM) system, which is widely used by individuals with Type 2 diabetes for convenient, real-time tracking. The high prevalence of Type 2 diabetes, combined with increasing preventive care initiatives and advanced monitoring technologies, supports its continued dominance in this market.
From a technology standpoint, minimally invasive systems are anticipated to play a central role due to their balance of comfort, accuracy, and continuous monitoring. These devices, commonly known as CGM systems, reduce the need for frequent finger-prick tests while providing real-time glucose readings via small wearable sensors. Their integration with smartphones and digital health platforms enhances convenience and patient engagement, making them ideal for long-term diabetes management. For example, Dexcom reported total revenue of $4.662 billion for fiscal year 2025, driven primarily by its sensor-based CGM systems, highlighting the strong market performance and adoption of this technology.
Diabetes Care Devices Market- Geographical Insights
From a geographical perspective, the Asia-Pacific region is poised for significant growth in the diabetes care devices market, driven by the rapidly increasing prevalence of diabetes and improving healthcare access across countries. According to the International Diabetes Federation (IDF), South-East Asia alone has over 100 million adults affected by diabetes, and this number is expected to rise sharply in the coming decades, creating strong demand for regular monitoring and effective disease management. Governments in the region are taking proactive measures through early screening programs, awareness campaigns, and enhanced healthcare services, particularly in developing economies. Simultaneously, companies such as Roche and Abbott Laboratories are expanding their presence with affordable, digitally enabled devices, including continuous glucose monitoring (CGM) solutions. The high number of undiagnosed cases further strengthens the need for advanced diagnostic and monitoring tools.
In India, the country is emerging as a major contributor within the region due to its large patient population and increasing awareness of diabetes care. IDF data indicates nearly 90 million adults in India are living with diabetes, highlighting the critical need for consistent monitoring solutions. The Ministry of Health and Family Welfare supports early detection and management through national programs targeting non-communicable diseases. Concurrently, companies are introducing budget-friendly and user-friendly devices, such as portable glucose monitors and connected digital tools, to serve a diverse population. Overall, rising awareness, improving healthcare infrastructure, and a growing focus on preventive care are driving the adoption of diabetes care devices across Asia-Pacific.
In North America, meaningful growth is also expected, supported by a high disease burden and advanced healthcare infrastructure. According to the Centers for Disease Control and Prevention (CDC), approximately 40.1 million people in the United States are living with diabetes, representing nearly 12% of the population. The region also accounts for some of the highest global healthcare expenditures on diabetes, reflecting strong spending capacity and access to advanced devices. Government initiatives, including awareness campaigns and funding for prevention and management, further support early diagnosis and continuous monitoring. Leading companies such as Dexcom and Tandem Diabetes Care continue to introduce innovative and connected solutions, including real-time monitoring systems and automated insulin delivery devices. The combination of high patient awareness, supportive policies, and a strong innovation ecosystem is steadily driving diabetes care device adoption in North America.
Diabetes Care Devices Market- Country Insights
Japan represents a mature and steadily growing market for diabetes care devices, driven by its aging population and rising prevalence of diabetes. According to the Ministry of Health, Labour and Welfare, a significant portion of the population is either living with diabetes or at high risk, creating a consistent demand for effective monitoring and management solutions. The government actively promotes early detection and long-term care through regular health check-ups, screening programs, and awareness campaigns, encouraging timely diagnosis and intervention. From an industry standpoint, companies such as Terumo Corporation and Roche provide advanced and reliable solutions, including glucose monitoring systems and insulin delivery devices. Japan’s emphasis on innovation has also resulted in the development of compact, user-friendly, and technologically sophisticated products. Overall, the combination of a supportive healthcare system, high public awareness, and continuous technological advancements is driving steady adoption of diabetes care devices in the country.
Diabetes Care Devices Market- Competitive Landscape:
The Diabetes Care Devices market is highly competitive and innovation-driven, shaped by a mix of global leaders and regional players. Companies such as Medtronic, Abbott Laboratories, Dexcom, and Insulet Corporation compete through advanced product offerings and patient-centric technologies. Devices are distributed via hospitals, pharmacies, online platforms, and direct-to-consumer channels. Competition centers on factors such as accuracy, ease of use, connectivity, pricing, and brand reliability, as companies strive to simplify daily diabetes management. To strengthen their market positions, companies focus on continuous innovation, strategic partnerships, and expanding digital health ecosystems. For example, Abbott formed a global partnership with Medtronic to integrate its FreeStyle Libre CGM technology with Medtronic’s insulin delivery systems, creating a more connected and automated diabetes care solution. Similarly, Insulet Corporation expanded its Omnipod 5 system with multi-sensor compatibility and broader availability, offering greater flexibility for users. Overall, the market is trending toward more connected, automated, and patient-focused solutions, driving ongoing collaboration and technological advancement among leading players.
Recent Developments:
- In January 2026, Abbott partnered with Withings to integrate its Lingo over-the-counter CGM technology into Withings’ digital health ecosystem. This collaboration aims to expand glucose monitoring access to millions of users, supporting preventive health tracking and strengthening data-driven metabolic health management.
- In December 2025, Medtronic launched an insulin delivery system integrated with Abbott’s CGM sensors, marking its first integration with an external CGM technology. This development enhances treatment efficiency, expands device compatibility, and enables more personalized and automated diabetes management, improving patient outcomes globally.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DIABETES CARE DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Dexcom
- Abbott Laboratories
- Medtronic
- Roche
- Ascensia Diabetes Care
- LifeScan
- B.Braun
- Ypsomed
- Tandem Diabetes Care
- Insulet Corporation
- Senseonics
- i-SENS
- Trividia Health
- AgaMatrix
- Sanofi
- Eli Lilly and Company
- Johnson & Johnson
- F. Hoffmann-La Roche
- Medtrum
- Nipro Corporation
- Others
GLOBAL DIABETES CARE DEVICES MARKET, BY DIABETES- MARKET ANALYSIS, 2020 - 2033
- Type 1
- Type 2
- Gestational
GLOBAL DIABETES CARE DEVICES MARKET, BY DEVICE- MARKET ANALYSIS, 2020 - 2033
- Self-Monitoring Devices
- Continuous Glucose Monitoring Systems (CGM)
- Insulin Delivery Devices
GLOBAL DIABETES CARE DEVICES MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033
- Retail Pharmacies
- Online Platforms
- Hospitals
GLOBAL DIABETES CARE DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Invasive (finger-prick glucose meters)
- Minimally Invasive (sensor-based)
- Non-Invasive (emerging technologies without blood samples)
GLOBAL DIABETES CARE DEVICES MARKET, BY END-USE- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Home-Care
- Diagnostic Centers
GLOBAL DIABETES CARE DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Diabetes Care Devices Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Diabetes Care Devices Market Snippet by Diabetes
2.1.2. Diabetes Care Devices Market Snippet by Device
2.1.3. Diabetes Care Devices Market Snippet by Distribution Channel
2.1.4. Diabetes Care Devices Market Snippet by Technology
2.1.5. Diabetes Care Devices Market Snippet by End-Use
2.1.6. Diabetes Care Devices Market Snippet by Country
2.1.7. Diabetes Care Devices Market Snippet by Region
2.2. Competitive Insights
3. Diabetes Care Devices Key Market Trends
3.1. Diabetes Care Devices Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Diabetes Care Devices Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Diabetes Care Devices Market Opportunities
3.4. Diabetes Care Devices Market Future Trends
4. Diabetes Care Devices Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Diabetes Care Devices Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Diabetes Care Devices Market Landscape
6.1. Diabetes Care Devices Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Diabetes Care Devices Market – By Diabetes
7.1. Overview
7.1.1. Segment Share Analysis, By Diabetes, 2025 & 2033 (%)
7.1.2. Type 1
7.1.3. Type 2
7.1.4. Gestational
8. Diabetes Care Devices Market – By Device
8.1. Overview
8.1.1. Segment Share Analysis, By Device, 2025 & 2033 (%)
8.1.2. Self-Monitoring Devices
8.1.3. Continuous Glucose Monitoring Systems (CGM)
8.1.4. Insulin Delivery Devices
9. Diabetes Care Devices Market – By Distribution Channel
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
9.1.2. Retail Pharmacies
9.1.3. Online Platforms
9.1.4. Hospitals
10. Diabetes Care Devices Market – By Technology
10.1. Overview
10.1.1. Segment Share Analysis, By Device, 2025 & 2033 (%)
10.1.2. Invasive
10.1.3. Minimally Invasive
10.1.4. Non-Invasiv
11. Diabetes Care Devices Market – By End-Use
11.1. Overview
11.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
11.1.2. Hospitals
11.1.3. Home-Care
11.1.4. Diagnostic Centers
12. Diabetes Care Devices Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Diabetes Care Devices Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Diabetes Care Devices Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Diabetes Care Devices Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Diabetes Care Devices Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Diabetes Care Devices Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Diabetes, 2020 - 2033 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Device, 2020 - 2033 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Diabetes Care Devices Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Dexcom
13.2.2. Abbott Laboratories
13.2.3. Medtronic
13.2.4. Roche
13.2.5. Ascensia Diabetes Care
13.2.6. LifeScan
13.2.7. B.Braun
13.2.8. Ypsomed
13.2.9. Tandem Diabetes Care
13.2.10. Insulet Corporation
13.2.11. Senseonics
13.2.12. i-SENS
13.2.13. Trividia Health
13.2.14. AgaMatrix
13.2.15. Sanofi
13.2.16. Eli Lilly and Company
13.2.17. Johnson & Johnson
13.2.18. F. Hoffmann-La Roche
13.2.19. Medtrum
13.2.20. Nipro Corporation
13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DIABETES CARE DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Dexcom
- Abbott Laboratories
- Medtronic
- Roche
- Ascensia Diabetes Care
- LifeScan
- B.Braun
- Ypsomed
- Tandem Diabetes Care
- Insulet Corporation
- Senseonics
- i-SENS
- Trividia Health
- AgaMatrix
- Sanofi
- Eli Lilly and Company
- Johnson & Johnson
- F. Hoffmann-La Roche
- Medtrum
- Nipro Corporation
- Others
GLOBAL DIABETES CARE DEVICES MARKET, BY DIABETES- MARKET ANALYSIS, 2020 - 2033
- Type 1
- Type 2
- Gestational
GLOBAL DIABETES CARE DEVICES MARKET, BY DEVICE- MARKET ANALYSIS, 2020 - 2033
- Self-Monitoring Devices
- Continuous Glucose Monitoring Systems (CGM)
- Insulin Delivery Devices
GLOBAL DIABETES CARE DEVICES MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033
- Retail Pharmacies
- Online Platforms
- Hospitals
GLOBAL DIABETES CARE DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Invasive (finger-prick glucose meters)
- Minimally Invasive (sensor-based)
- Non-Invasive (emerging technologies without blood samples)
GLOBAL DIABETES CARE DEVICES MARKET, BY END-USE- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Home-Care
- Diagnostic Centers
GLOBAL DIABETES CARE DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
